Glaxosmithkline Share News (GSK)

Europe backs new leukaemia drugs from J&J and Gilead

LONDON, July 25 (Reuters) - Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months. The European Medicines Agency said on Friday its experts had issued positive op

UK WINNERS & LOSERS: Carillion, Balfour Up As Merger Talks Confirmed

TOP NEWS: RBS Surprises With Strong Profits; BSkyB Buys Fox Stakes

Banks outpace flat UK FTSE after RBS's bumper results

* FTSE 100 flat * RBS jumps 14 pct as UK upturn boosts results * GSK pegs back FTSE on corruption allegations By Francesco Canepa LONDON, July 25 (Reuters) - British lenders who focus on the domestic market outpaced a flat FTSE 100 index on Friday after strong results from

Friday broker round-up UPDATE

African Barrick Gold: Investec places both its target price (prev.: 212p) and its sell recommendation under review. Westhouse Securities ups target price from 250p to 285p upgrading from neutral to add. Barclays: Deutsche Bank cuts target price from 300p to 275p staying with its buy recommendation.

UK BROKER RATINGS: UBS Cuts GlaxoSmithKline To Sell From Neutral

Britain's FTSE edges down ahead of growth data, RBS soars

* FTSE 100 down 0.1 pct, investor sentiment muted on earnings * Q2 GDP data in focus after IMF upgrades * RBS jumps 14 pct, biggest one-day gain in four years * BSkyB deal hits shares, Burberry weaker on LVMH LONDON, July 25 (Reuters) - UK shares edged lower in early tradi

UK MORNING BRIEFING: BSkyB And Balfour-Carillion Put M&A In Focus

PRESS: GlaxoSmithKline Facing Bribery Allegations In Syria - Reuters

GSK seeks regulatory approval for world's first malaria vaccine

GlaxoSmithKline (GSK) has applied for regulatory approval for the world's first vaccine against malaria. The UK drugmaker's shot RTS,S has been designed for children in Africa. It is intended exclusively for use outside the European Union, but the European Medicines Agency (EMA) will evaluate the

UPDATE 2-GSK seeks approval for world's first malaria vaccine

* RTS,S vaccine designed for babies, children * Mosquito-borne malaria kills over 600,000 people a year * British drugmaker pledges to make shot affordable for poor * U.S. partner Agenus earns milestone payment on filing (Adds Agenus milestone payment, share price) By Ka

Glaxo Submits European Regulatory Application For Malaria Vaccine

Atox Bio raises $23 mln to fund flesh-eating bacteria treatment

TEL AVIV, July 24 (Reuters) - Israel-based Atox Bio, a developer of therapeutics for severe infections, said on Thursday it has raised $23 million in an investment round led by SR One, the healthcare venture capital fund of GlaxoSmithKline . Lundbeck's Lundbeckfond Ventures and OrbiMed Isra

GSK seeks approval for world's first malaria vaccine

LONDON, July 24 (Reuters) - GlaxoSmithKline is applying for regulatory approval for the world's first vaccine against malaria, designed for use in children in Africa. The British drugmaker said the shot, called RTS,S, is intended exclusively for use outside the European Union but will be ev

UK BROKER RATINGS: Jefferies Raises Antofagasta To Buy From Hold